Werfen
Pioneering next-generation clinical diagnostics through innovation and sustainability
Spanish diagnostics giant emerges as global leader in specialised laboratory solutions
Werfen, the Barcelona-based family-owned diagnostics company founded in 1966, has evolved into a worldwide leader in specialised clinical diagnostics, operating directly in 30 countries with distribution across more than 100 territories. With worldwide sales approaching €2.2 billion in 2024 and a workforce of 7,000 professionals, the company has established itself as a formidable force in the global in vitro diagnostics (IVD) market.
Clinical excellence across critical diagnostic areas
Werfen’s expertise spans five critical clinical areas: Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant diagnostics. This comprehensive portfolio positions the company at the forefront of laboratory medicine’s most demanding applications.
Hemostasis innovation: The company’s Hemostasis product portfolio comprises in vitro diagnostic systems, reagents, data management solutions, automation, and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. These solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
Acute care diagnostics: From cardiovascular operating rooms and catheterisation labs to intensive care units and emergency departments, Werfen’s Acute Care Diagnostic solutions are integrated and comprehensive. This whole blood testing portfolio helps clinicians and laboratorians save time, lower costs, assure regulatory compliance and improve patient outcomes.
Transfusion medicine: Offering the broadest range of manual and automated solutions, the Transfusion portfolio delivers results accurately, efficiently and productively. A comprehensive line of serology reagents, fully automated instrumentation, industry-leading data management software and molecular products help ensure donor-recipient compatibility for those in need of lifesaving blood transfusion.
Autoimmunity leadership: Through a dedicated focus on in vitro diagnostics and lab automation for Autoimmunity, the company’s precise reagents and automated systems are designed to serve labs of all sizes. Werfen’s solutions help improve the way patients with Autoimmune diseases are diagnosed, monitored, and treated.
Transplant diagnostics: Featuring molecular and antibody-based assays and software for specialised human leukocyte antigen (HLA) testing, Werfen’s Transplant products are used to determine pretransplant compatibility between donors and recipients, and for post-transplant monitoring.
Technological innovation at the core
With Technology Centers located in the United States and Europe, alongside headquarters in Barcelona, Spain, Werfen maintains a robust innovation infrastructure. The company’s commitment to technological advancement is evident in its development of intuitive, reliable, and intelligent diagnostic solutions that meet the needs of both large laboratory networks and small hospitals.
Sustainability leadership: The 3P framework
Werfen believes in the importance of sustainability for people, planet and profitability. As a signatory of the UN Global Compact, the company commits to the UN Sustainable Development Goals.
People: The company’s commitment to human rights, security, equality, inclusion and diversity encompasses freedom of expression, gender identity equality, and non-discrimination in employment. Werfen prohibits all forms of forced labour and illegal child labour whilst ensuring safe and healthy working environments with fair wages and working conditions.
Planet: Environmental protection initiatives focus on CO2 emissions reduction, waste management, and biodiversity preservation through comprehensive climate change action, responsible water management, air quality control, and sustainable energy practices.
Prosperity: Economic development through efficient resource utilisation, including energy and materials management, ensures sustainable growth whilst maintaining profitability.
Corporate philosophy: Powering patient care
In everything they do, Werfen uses passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide. This patient-centric philosophy drives the company’s research, development, and manufacturing of immunoassay and biomaterial solutions for the IVD industry.
As outlined in their comprehensive ESG policies approved by the Chairman, CEO and CFO, Werfen demonstrates unwavering commitment to anti-corruption practices, ensuring ethical business conduct across all operations. Through this combination of technological excellence, comprehensive clinical coverage, and unwavering commitment to sustainability, Werfen continues to innovate and advance clinical laboratory diagnostics, delivering solutions that improve both scientific knowledge and patient outcomes globally.
Contact Werfen Headquarters
Address Plaza de Europa nº 21-23
08908 L’Hospitalet de Llobregat
Barcelona, Spain
Phone +34 934 010 101
Website www.werfen.com
